Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Seizure Induced Respiratory Depression in Epilepsy
NCT02929667Phase 2Completed
- Start
- Feb 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluoxetine in epilepsy and sudden unexpected death in epilepsy (SUDEP) (2 arms). Primary endpoints: Study Recruitment Rate and Study Retention Rate. Started Feb 2017; status: completed.
02
Drugs
fluoxetine
03
Conditions
epilepsysudden unexpected death in epilepsy (SUDEP)
Beyond the preview
Go deeper on NCT02929667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929667.